nodes	percent_of_prediction	percent_of_DWPC	metapath
Atenolol—ADRB1—Adrenoceptors—ADRA2C—attention deficit hyperactivity disorder	0.0665	0.0676	CbGpPWpGaD
Atenolol—ADRB2—Adrenoceptors—ADRA2C—attention deficit hyperactivity disorder	0.065	0.0661	CbGpPWpGaD
Atenolol—ADRB1—Adrenoceptors—ADRA2A—attention deficit hyperactivity disorder	0.0349	0.0355	CbGpPWpGaD
Atenolol—ADRB2—Adrenoceptors—ADRA2A—attention deficit hyperactivity disorder	0.0341	0.0347	CbGpPWpGaD
Atenolol—ADRB1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0235	0.0239	CbGpPWpGaD
Atenolol—ADRB1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.023	0.0234	CbGpPWpGaD
Atenolol—ADRB2—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.023	0.0234	CbGpPWpGaD
Atenolol—ADRB2—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0225	0.0229	CbGpPWpGaD
Atenolol—ADRB1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0198	0.0201	CbGpPWpGaD
Atenolol—ADRB1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0194	0.0197	CbGpPWpGaD
Atenolol—ADRB2—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0193	0.0197	CbGpPWpGaD
Atenolol—ADRB2—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0189	0.0193	CbGpPWpGaD
Atenolol—ADRB1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0139	0.0142	CbGpPWpGaD
Atenolol—ADRB2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0136	0.0139	CbGpPWpGaD
Atenolol—ADRB1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0134	0.0136	CbGpPWpGaD
Atenolol—ADRB2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0131	0.0133	CbGpPWpGaD
Atenolol—ADRB1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.013	0.0132	CbGpPWpGaD
Atenolol—ADRB2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0127	0.0129	CbGpPWpGaD
Atenolol—ADRB1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0126	0.0128	CbGpPWpGaD
Atenolol—ADRB1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0123	0.0126	CbGpPWpGaD
Atenolol—ADRB2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0123	0.0125	CbGpPWpGaD
Atenolol—ADRB1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0122	0.0124	CbGpPWpGaD
Atenolol—ADRB2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0121	0.0123	CbGpPWpGaD
Atenolol—ADRB2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0119	0.0121	CbGpPWpGaD
Atenolol—ADRB1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0117	0.0119	CbGpPWpGaD
Atenolol—ADRB2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0115	0.0117	CbGpPWpGaD
Atenolol—ADRB1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0114	0.0116	CbGpPWpGaD
Atenolol—ADRB2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0111	0.0113	CbGpPWpGaD
Atenolol—ADRB1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0109	0.0111	CbGpPWpGaD
Atenolol—Pindolol—HTR1B—attention deficit hyperactivity disorder	0.0109	0.647	CrCbGaD
Atenolol—ADRB1—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.0108	0.011	CbGpPWpGaD
Atenolol—ADRB2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0107	0.0108	CbGpPWpGaD
Atenolol—ADRB1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0106	0.0107	CbGpPWpGaD
Atenolol—ADRB1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0104	0.0106	CbGpPWpGaD
Atenolol—ADRB2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0103	0.0105	CbGpPWpGaD
Atenolol—ADRB1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0102	0.0104	CbGpPWpGaD
Atenolol—ADRB2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0102	0.0103	CbGpPWpGaD
Atenolol—ADRB2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.01	0.0102	CbGpPWpGaD
Atenolol—ADRB1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00955	0.00971	CbGpPWpGaD
Atenolol—ADRB2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00934	0.0095	CbGpPWpGaD
Atenolol—ADRB1—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00798	0.00812	CbGpPWpGaD
Atenolol—ADRB1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00796	0.00809	CbGpPWpGaD
Atenolol—ADRB2—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00781	0.00794	CbGpPWpGaD
Atenolol—ADRB2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00778	0.00792	CbGpPWpGaD
Atenolol—ADRB1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00669	0.0068	CbGpPWpGaD
Atenolol—ADRB2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00654	0.00665	CbGpPWpGaD
Atenolol—Propranolol—HTR1B—attention deficit hyperactivity disorder	0.00593	0.353	CrCbGaD
Atenolol—ADRB2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00546	0.00555	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.0053	0.00539	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00454	0.00461	CbGpPWpGaD
Atenolol—ADRB1—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.0045	0.00457	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00444	0.00452	CbGpPWpGaD
Atenolol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00444	0.00452	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00444	0.00451	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00441	0.00449	CbGpPWpGaD
Atenolol—ADRB2—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.0044	0.00447	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00435	0.00442	CbGpPWpGaD
Atenolol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00435	0.00442	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00432	0.00439	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00389	0.00395	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00381	0.00387	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0038	0.00387	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00372	0.00379	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00346	0.00352	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00308	0.00313	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00301	0.00306	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00296	0.00301	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.0029	0.00295	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00289	0.00294	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00284	0.00288	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00269	0.00274	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00264	0.00268	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00263	0.00268	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00258	0.00263	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0025	0.00255	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00249	0.00254	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00245	0.00249	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00244	0.00248	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00242	0.00247	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00238	0.00242	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00237	0.00241	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00235	0.00239	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00233	0.00237	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00231	0.00235	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.0023	0.00234	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00226	0.0023	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00226	0.00229	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00221	0.00225	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00219	0.00223	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00214	0.00218	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00214	0.00218	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0021	0.00213	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00208	0.00211	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00204	0.00208	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00203	0.00207	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00202	0.00205	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00201	0.00204	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.002	0.00203	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00197	0.00201	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00197	0.002	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00188	0.00191	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00184	0.00187	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00176	0.00179	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00172	0.00175	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00168	0.00171	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00167	0.0017	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00164	0.00167	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00164	0.00166	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00163	0.00166	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00161	0.00163	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.0016	0.00163	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0016	0.00162	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00158	0.00161	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00155	0.00158	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00155	0.00157	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00154	0.00156	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00154	0.00156	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00152	0.00155	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00152	0.00154	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.0015	0.00153	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0015	0.00153	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00149	0.00151	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00149	0.00151	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00146	0.00148	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00143	0.00145	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.0014	0.00142	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00134	0.00136	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00132	0.00134	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00131	0.00133	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00129	0.00131	CbGpPWpGaD
Atenolol—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00126	0.00128	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.0012	0.00122	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00114	0.00115	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00111	0.00113	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00104	0.00106	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00103	0.00105	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00102	0.00104	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00101	0.00103	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.001	0.00102	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000993	0.00101	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00098	0.000997	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000971	0.000988	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000923	0.000939	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000903	0.000918	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000901	0.000917	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000897	0.000912	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000894	0.000909	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000882	0.000897	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000879	0.000894	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000878	0.000893	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000878	0.000893	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000874	0.000889	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000868	0.000882	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000862	0.000877	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00086	0.000874	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000859	0.000874	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000849	0.000863	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000843	0.000857	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000838	0.000852	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00082	0.000834	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000812	0.000825	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000808	0.000822	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000798	0.000811	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000794	0.000807	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000791	0.000804	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000788	0.000801	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00078	0.000794	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000771	0.000784	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000734	0.000746	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000718	0.00073	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000609	0.00062	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000596	0.000606	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000586	0.000596	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000566	0.000576	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000558	0.000567	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000554	0.000563	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000538	0.000547	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000532	0.000542	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000521	0.00053	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000514	0.000523	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000503	0.000511	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000495	0.000503	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000484	0.000493	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000479	0.000488	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000471	0.000479	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000469	0.000477	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000465	0.000473	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000461	0.000469	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000455	0.000463	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000434	0.000441	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000424	0.000431	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000385	0.000392	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000385	0.000392	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000379	0.000385	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000352	0.000358	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000308	0.000313	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000304	0.000309	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000297	0.000302	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000293	0.000298	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000233	0.000237	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000232	0.000236	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000161	0.000164	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000157	0.00016	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	0.0001	0.000102	CbGpPWpGaD
